News
News
- SIGA Announces Canadian Department of National Defence Intent to Purchase Up To 15,325 Courses of Oral TPOXX®
18:10 - GlobeNewswire - Galectin Therapeutics Plans Adaptively Designed Phase 3 NASH-RX Clinical Trial in NASH Cirrhosis
18:06 - GlobeNewswire - Trex Helps Make a Coastal Dream Come True
18:00 - GlobeNewswire - EANS-Voting Rights: Wienerberger AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act EAE
18:00 - euro adhoc - Sunesis Pharmaceuticals Announces Data from Ongoing Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies
17:41 - GlobeNewswire - AgJunction Announces Appointment of Interim President and Chief Executive Officer
17:32 - GlobeNewswire - Blue Star Engages Mackie Research Capital Corp as Trading Advisor
17:24 - Newsfile Corp - BAB, Inc. Announces Cash Distribution
17:15 - GlobeNewswire - Freddie Mac Prices $599 Million Multifamily K-Deal, K-C07
17:15 - GlobeNewswire - PAG Investments Acquires Simsbury Commons for $46.5 Million
17:00 - GlobeNewswire
Real-time